Trial Profile
Clinical Trials Insight: 700028784
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 26 Nov 2007
Price :
$35
*
At a glance
- Drugs Lorazepam (Primary)
- Indications Epilepsy; Seizures; Status epilepticus
- Focus Adverse reactions
- Sponsors Amarin Corporation
- 26 Nov 2007 New trial record.